No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
BYON241220P5000
- 0.10
- +0.04+66.67%
15min DelayClose Dec 13 16:00 ET
0.13High0.10Low
0.10Open0.06Pre Close15 Volume750 Open Interest5.00Strike Price153.00Turnover89.42%IV6.67%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type-0.2916Delta0.6624Gamma52.50Leverage Ratio-0.0207Theta-0.0002Rho-15.31Eff Leverage0.0020Vega
Intraday
- 5D
- Daily
News
Serina Therapeutics to Present at Tribe Public's Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024
Qualcomm (QCOM) Names Dr. Baaziz Achour as New CTO: Leading the Charge Into 6G and Beyond
3 Market-Beating Tech Stocks to Supercharge Your Portfolio in 2025 and Beyond
These 2 Dow Stocks Are Set to Soar in 2025 and Beyond
Amazon and Bitcoin, Crypto Tips, and Beyond the Magnificent 7: Markets News Roundup
Enanta Pharmaceuticals: Undervalued Potential Beyond Hepatitis C – Buy Recommendation by Roy Buchanan